Skip to main content

Onkologie und Hämatologie | Zeitschrift

memo - Magazine of European Medical Oncology 3/2022
memo - Magazine of European Medical Oncology

Ausgabe 3/2022


Inhaltsverzeichnis (19 Artikel)

01.09.2022 | editorial

CAR-T cells—Real-time experience applying CAR-T cells—What we have learned so far
Univ.-Prof. Dr. Hildegard Greinix

01.09.2022 | editorial

Molecular profiling leading to personalized cancer treatment
Ap. Prof. PDin scient. med. Barbara Kiesewetter

01.09.2022 | editorial

Neoadjuvant treatment for solid tumors—the earlier, the better
Univ.-Prof. Dr. Rupert Bartsch, Prof. Dr. Wolfgang Hilbe

19.07.2022 | short review

Real time experience applying CAR T-cells for B-cell lymphoma—What we have learned so far: Acute toxicity management
Dr. Emine Kaynak, Dr. Johannes Clausen

17.08.2022 | short review

CAR T cells in multiple myeloma: Where we stand and where we might be going
PD Dr. Niklas Zojer, Dr. Martin Schreder, Univ.-Prof. Dr. Heinz Ludwig

Open Access 13.04.2022 | review

Applicability of ESMO-MCBS and ESCAT for molecular tumor boards Ladislaia Wolff, Ap. Prof. PD Dr. Dr. Barbara Kiesewetter

Open Access 15.02.2022 | short review

Molecular profiling leading to personalized treatment in breast cancer
Dr. med. univ. Eva Valentina Klocker, Assoz. Prof. PD Dr. med. univ. et scient. med. Marija Balic, Univ.-Prof. Dr. Günther Steger

Open Access 19.07.2022 | short review

Molecular profiling in lung cancer
Laurenz Nagl, Georg Pall, Dominik Wolf, Andreas Pircher, Lena Horvath

29.08.2022 | short review

Molecular profiling in colorectal cancer
Gudrun Piringer Msc

19.07.2022 | short review

Neoadjuvant treatment in gastric cancer
Bettina Sonnweber, Marc Schaber, Ewald Wöll MD

Open Access 24.08.2022 | short review

Neoadjuvant treatment in non-small-cell lung cancer—the earlier, the better
Angelika Terbuch, Gudrun Absenger

10.08.2022 | short review

Neoadjuvant treatment of pancreatic ductal adenocarcinoma
Katharina Kosma, Sabine Thalhammer, Thomas Gruenberger

06.07.2022 | short review

Neoadjuvant treatment in solid tumors—the earlier, the better in breast cancer
Dr. Renate Pusch

08.06.2021 | case report

Breast implant-associated anaplastic large-cell lymphoma: a European case report and literature review
Federico Ghidinelli M.D., Luigi Filippini M.D., Paola Porsio M.D., Federico Canzi M.D., Rino Balzano M.D., Elisa Flocchini M.D., Anna Bianchi M.D.

11.07.2022 | comment

Breast implant-associated anaplastic large-cell lymphoma—update on challenges, advances and opportunities
Andreas Pircher MD PhD, Roberto N. Miranda

09.05.2022 | short review

Essential news and practice changing trials in oesophageal, gastroesophageal junction and gastric cancer in 2021
Patrick Reimann, Thomas Winder

19.07.2022 | case report

Multiple myeloma with central nervous system relapse: a case report
Petra Marics, Wolfgang Pokieser, Nikolaus Neubauer, Georg Slavka, Wolfgang Hilbe, Martin Schreder

25.08.2022 | original report

Systemic inflammatory response index is a prognostic biomarker in unresectable pancreatic adenocarcinoma and identifies patients for more intensive treatment
Sara Dâmaso MD, Rita Paiva MD, Inês Pinho MD, Miguel Esperança-Martins MD, Raquel Lopes Brás MD, Cecília Melo Alvim MD, António Quintela MD, Ana Lúcia Costa MD, Luís Costa MD

Open Access 17.08.2022 | Publisher Correction

Publisher Correction: Brain metastases: new systemic treatment approaches
Ariane Steindl MD PhD, Anna Sophie Berghoff